SAGE Therapeutics Announces Strategic Reorganization Amid Executive Departures
Company Announcements

SAGE Therapeutics Announces Strategic Reorganization Amid Executive Departures

SAGE Therapeutics ( (SAGE) ) just unveiled an update.

Sage Therapeutics, Inc. has announced a strategic reorganization involving the departure of key executives, including CFO Kimi Iguchi and General Counsel Anne Marie Cook. Their separation agreements offer continued salary, healthcare coverage, and bonuses, while Iguchi will also consult until March 2025. Both executives have adjusted stock options, emphasizing the company’s focus on restructuring and operational efficiency, a move closely watched by investors and market analysts.

Find detailed analytics on SAGE stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySage Therapeutics price target lowered to $8 from $13 at Truist
TheFlySage Therapeutics price target lowered to $8 from $9 at Oppenheimer
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App